Science Explorer Back to mapMap
Discussion

PaxVax (United States)

Research works
27
▼ 16% vs 2018-21
Citations
1.1k
39.0 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
66%
world 40%
International
26%
world 18%

Not ranked overall: PaxVax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PaxVax (United States) work in?

In all years, 44% of research at PaxVax (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (11%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 12 fractional works · 44.3% of its workMedicine: 11 fractional works · 39.9% of its workInfectious Diseases: 3 fractional works · 11.4% of its workEpidemiology: 2 fractional works · 6.6% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 6.3% of its workOncology: 1 fractional works · 3.8% of its workGenetics: 1 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workHepatology: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 2.8% of its workGeneral Health Professions: 0 fractional works · 1.5% of its workOccupational Therapy: 0 fractional works · 0.6% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.8% of its workNutrition and Dietetics: 0 fractional works · 0.8% of its workVeterinary: 0 fractional works · 0.8% of its workSmall Animals: 0 fractional works · 0.8% of its workLife Sciences: 10 fractional works · 37.6% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 20.9% of its workEndocrinology: 2 fractional works · 7.5% of its workMolecular Biology: 2 fractional works · 6.9% of its workGenetics: 1 fractional works · 3.8% of its workCancer Research: 0 fractional works · 1.8% of its workBiotechnology: 0 fractional works · 0.9% of its workImmunology and Microbiology: 3 fractional works · 11.2% of its workImmunology: 2 fractional works · 5.8% of its workParasitology: 1 fractional works · 4.0% of its workVirology: 0 fractional works · 1.3% of its workAgricultural and Biological Sciences: 1 fractional works · 4.8% of its workInsect Science: 0 fractional works · 1.8% of its workAnimal Science and Zoology: 0 fractional works · 1.5% of its workAgronomy and Crop Science: 0 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workPhysical Sciences: 3 fractional works · 10.7% of its workEngineering: 2 fractional works · 5.7% of its workBiomedical Engineering: 1 fractional works · 2.5% of its workElectrical and Electronic Engineering: 0 fractional works · 1.7% of its workControl and Systems Engineering: 0 fractional works · 1.2% of its workMechanics of Materials: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 2.7% of its workArtificial Intelligence: 0 fractional works · 0.6% of its workComputer Networks and Communications: 0 fractional works · 0.6% of its workHuman-Computer Interaction: 0 fractional works · 0.6% of its workInformation Systems: 0 fractional works · 0.6% of its workSignal Processing: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 1.6% of its workSurfaces, Coatings and Films: 0 fractional works · 1.2% of its workBiomaterials: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.6% of its workModeling and Simulation: 0 fractional works · 0.6% of its workSocial Sciences: 2 fractional works · 7.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.1% of its workEconomics and Econometrics: 0 fractional works · 1.8% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 1.2% of its workSocial Sciences: 1 fractional works · 2.2% of its workGeography, Planning and Development: 0 fractional works · 0.9% of its workHealth: 0 fractional works · 0.6% of its workEducation: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workManagement of Technology and Innovation: 0 fractional works · 1.2% of its workArts and Humanities: 0 fractional works · 0.9% of its workClassics: 0 fractional works · 0.9% of its workALL ITS WORKPaxVax (UnitedStates)27fractional works, all years
Life Sciences38%Physical Sciences11%Health Sciences44%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1139.9%
    2. Health Professions12.8%
    3. Nursing00.8%
    4. Veterinary00.8%
    1. Biochemistry, Genetics and Molecular Biology620.9%
    2. Immunology and Microbiology311.2%
    3. Agricultural and Biological Sciences14.8%
    4. Pharmacology, Toxicology and Pharmaceutics00.4%
    5. Neuroscience00.3%
    1. Engineering25.7%
    2. Computer Science12.7%
    3. Materials Science01.6%
    4. Mathematics00.6%
    1. Economics, Econometrics and Finance13.1%
    2. Social Sciences12.2%
    3. Business, Management and Accounting01.2%
    4. Arts and Humanities00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.12× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.39× its world share, 0 worksImmunology and Micro…Neuroscience: 1.23× its world share, 0 worksNeuroscienceComputer Science: 1.74× its world share, 1 worksComputer ScienceEngineering: 0.74× its world share, 0 worksEngineeringMedicine: 3.22× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.4×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology5.39×0 works
  2. Medicine3.22×3 works
  3. Computer Science1.74×1 works
  4. Neuroscience1.23×0 works
  5. Biochemistry, Genetics and Molecular Biology1.12×0 works
  6. Engineering0.74×0 works

Who are the top researchers at PaxVax (United States)?

Ranked on the quality score, Marc Gurwith and Darly Joseph Manayani lead among researchers whose main affiliation is PaxVax (United States).

  1. 1 Marc Gurwith United States · #204,992 worldwide 9.6k citations · 143 works
  2. 2 Darly Joseph Manayani United States · #3,981,284 worldwide 417 citations · 18 works
All ranked researchers at PaxVax (United States)

What are the most cited papers from PaxVax (United States)?

The most cited paper from PaxVax (United States) is "Yellow fever" (Thomas P. C. Monath, Pedro Fernando da Costa Vasconcelos, 2014), with 688 citations. Next come "Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus" (219) and "Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor" (209).

Most cited papers
#PaperReleasedCitations
1 Yellow fever Thomas P. C. Monath, Pedro Fernando da Costa Vasconcelos · Journal of Clinical Virology Open access 24 Oct 2014 688
2 Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus Kathryn A. Hanley, Thomas P. C. Monath, Scott C. Weaver et al. · Infection Genetics and Evolution Open access 20 Mar 2013 219
3 Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor Katherine Basore, Arthur S. Kim, Christopher A. Nelson et al. · Cell Open access 9 May 2019 209
4 Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick et al. · Clinical Infectious Diseases Open access 21 Mar 2016 201
5 Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family Donald B. Smith, Paul Becher, Jens Bukh et al. · Journal of General Virology Open access 30 Sep 2016 177
All 58 most cited papers, with filters and sorting

Which keywords describe research at PaxVax (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Immune Response, Vaccine Development, Genetic Diversity, Vaccine, Zoonotic Infections and Public Health.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Epidemiology8▲ 7.5×22 topics
  2. Pathogenesis4▲ 24×9 topics
  3. Immune Response4▲ 21×11 topics
  4. Vaccine Development2▲ 29×5 topics
  5. Genetic Diversity2▲ 16×3 topics
  6. Vaccine2▲ 18×8 topics
  7. Public Health2▲ 5.0×6 topics
  8. Zoonotic Infections2▲ 111×2 topics
  9. Immunotherapy2▲ 8.4×5 topics
  10. Pandemic2▲ 12×3 topics
  11. Zoonotic Transmission2▲ 53×4 topics
  12. Diagnosis1▲ 5.1×4 topics
  13. Gene Therapy1▲ 19×3 topics
  14. Genomic Analysis1▲ 18×4 topics
  15. Host-Pathogen Interactions1▲ 49×2 topics
  16. Vector Control1▲ 43×2 topics
  17. Innate Immunity1▲ 14×6 topics
  18. Vaccines1▲ 68×2 topics
  19. Antibodies1▲ 51×2 topics
  20. Bacterial Pathogenesis1▲ 94×2 topics
  21. Bunyavirus1▲ 91×1 topic
  22. Viral Hemorrhagic Fevers1▲ 91×1 topic
  23. Virus1▲ 36×2 topics
  24. Cholera1▲ 153×1 topic
  25. Genomics1▲ 12×2 topics
  26. Regulation1▲ 6.7×2 topics
  27. Vibrio cholerae1▲ 153×1 topic
  28. H1N11▲ 107×1 topic
  29. Influenza1▲ 81×1 topic

Which research topics does PaxVax (United States) publish most on?

By volume in 2022-now: Glioma Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers and Cancer Genomics and Diagnostics.

  1. 1 Glioma Diagnosis and Treatment Genetics 1 works
  2. 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Mobile Agent-Based Network Management Computer Networks and Communications 0 works
  6. 6 Service-Oriented Architecture and Web Services Information Systems 0 works
  7. 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 0 works
  9. 9 Multi-Agent Systems and Negotiation Artificial Intelligence 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.2%not open33.8%

World: 40% of research is openly available.

with international co-authors25.5%domestic only74.5%

World: 18% is written across borders.

How has PaxVax (United States)'s research output changed?

Output in 2022-2025 was 16% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PaxVax (United States) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.00010%0.00020%PaxVax (United States)0.000025% in 2025200020102020

Fractional works of PaxVax (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PaxVax (United States). Posts are plain text and can be reported.